Annual Shareholders Equity
$111.47 M
-$187.20 M-62.68%
31 December 2023
Summary:
Autolus Therapeutics annual stockholders equity is currently $111.47 million, with the most recent change of -$187.20 million (-62.68%) on 31 December 2023. During the last 3 years, it has fallen by -$201.85 million (-64.42%). AUTL annual shareholders equity is now -64.42% below its all-time high of $313.32 million, reached on 31 December 2021.AUTL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$476.96 M
-$50.88 M-9.64%
30 September 2024
Summary:
Autolus Therapeutics quarterly stockholders equity is currently $476.96 million, with the most recent change of -$50.88 million (-9.64%) on 30 September 2024. Over the past year, it has increased by +$365.49 million (+327.87%). AUTL quarterly shareholders equity is now -18.05% below its all-time high of $582.03 million, reached on 31 March 2024.AUTL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUTL Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +327.9% |
3 y3 years | -64.4% | +52.2% |
5 y5 years | -56.3% | +87.2% |
AUTL Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -64.4% | at low | -18.1% | +327.9% |
5 y | 5 years | -64.4% | at low | -18.1% | +327.9% |
alltime | all time | -64.4% | +263.3% | -18.1% | +327.9% |
Autolus Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $476.96 M(-9.6%) |
June 2024 | - | $527.84 M(-9.3%) |
Mar 2024 | - | $582.03 M(+422.1%) |
Dec 2023 | $111.47 M(-62.7%) | $111.47 M(-38.2%) |
Sept 2023 | - | $180.52 M(-21.3%) |
June 2023 | - | $229.34 M(-14.1%) |
Mar 2023 | - | $266.92 M(-10.6%) |
Dec 2022 | $298.67 M(-4.7%) | $298.67 M(+85.3%) |
Sept 2022 | - | $161.15 M(-24.9%) |
June 2022 | - | $214.52 M(-20.9%) |
Mar 2022 | - | $271.14 M(-13.5%) |
Dec 2021 | $313.32 M | $313.32 M(+28.0%) |
Sept 2021 | - | $244.73 M(-13.7%) |
June 2021 | - | $283.68 M(-5.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $299.57 M(+42.6%) |
Dec 2020 | $210.03 M(-17.6%) | $210.03 M(-11.3%) |
Sept 2020 | - | $236.81 M(-8.6%) |
June 2020 | - | $258.95 M(-9.9%) |
Mar 2020 | - | $287.48 M(+12.8%) |
Dec 2019 | $254.84 M(+9.5%) | $254.84 M(-5.5%) |
Sept 2019 | - | $269.64 M(-9.6%) |
June 2019 | - | $298.22 M(+36.9%) |
Mar 2019 | - | $217.88 M(+71.4%) |
Dec 2018 | $232.64 M(-8.9%) | - |
Sept 2018 | $255.47 M(+79.1%) | - |
Mar 2018 | - | $127.10 M |
Sept 2017 | $142.60 M(+364.7%) | - |
Sept 2016 | $30.69 M | - |
FAQ
- What is Autolus Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly shareholders equity year-on-year change?
What is Autolus Therapeutics annual stockholders equity?
The current annual shareholders equity of AUTL is $111.47 M
What is the all time high annual shareholders equity for Autolus Therapeutics?
Autolus Therapeutics all-time high annual stockholders equity is $313.32 M
What is Autolus Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AUTL is $476.96 M
What is the all time high quarterly shareholders equity for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly stockholders equity is $582.03 M
What is Autolus Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AUTL quarterly stockholders equity has changed by +$365.49 M (+327.87%)